BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3481543)

  • 1. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T; Nolasco I; Hibbin J; Goldman JM
    Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
    Lu L; Pelus LM; Broxmeyer HE
    Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.
    Goldman JM; Hibbin J; Kearney L; Orchard K; Th'ng KH
    Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
    Dowding CR; Gordon MY; Goldman JM
    Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement sensitivity of erythroid and myeloid precursors in paroxysmal in nocturnal hemoglobinuria.
    Ishida Y; Matsumoto N; Shinohara K; Yamada K; Inoue M; Kaneko T; Murphy MJ
    Int J Cell Cloning; 1984 Sep; 2(5):316-26. PubMed ID: 6491393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T; Hast R; Goldman JM
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells.
    Falkenburg JH; Koning F; Duinkerken N; Fibbe WE; Voogt PJ; Jansen J
    Exp Hematol; 1986 Feb; 14(2):90-6. PubMed ID: 3002833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
    Hast R; Dowding C; Robak T; Goldman JM
    Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):17-28. PubMed ID: 2619501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
    Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
    Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic expression and proliferative status of multilineage myeloid progenitor cells (CFU-GEMM) in normal individuals and patients with chronic granulocytic leukaemia.
    Hibbin JA; McCarthy DM; Goldman JM
    Scand J Haematol; 1983 Nov; 31(5):454-60. PubMed ID: 6580719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C; Miura Y
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
    Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
    Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.